# Radiation Dose Study of Concurrent Chemoradiotherapy With Cisplatin Plus Fluorouracil in Oesophageal Cancer

> **NCT01646853** · NA · UNKNOWN · sponsor: **Simcere Pharmaceutical Co., Ltd** · enrollment: 500 (estimated)

## Conditions studied

- Esophageal Neoplasms

## Interventions

- **RADIATION:** Megavoltage photon beam
- **DRUG:** cisplatin-fluorouracil chemotherapy

## Key facts

- **NCT ID:** NCT01646853
- **Lead sponsor:** Simcere Pharmaceutical Co., Ltd
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-08
- **Primary completion:** 2013-12
- **Final completion:** —
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2012-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01646853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01646853, "Radiation Dose Study of Concurrent Chemoradiotherapy With Cisplatin Plus Fluorouracil in Oesophageal Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01646853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*